Crystalline Form Of Sphingosine 1 Phosphate Receptor Agonist

Abstract: The present invention relates to a crystalline form of a sphingosine-1-phosphate receptor agonist and, more particularly, to a crystalline form of 1-[1-chloro-6-(3-chloro-1-isopropyl-1H-indazol-5-ylmethoxy)-3,4-dihydro-naphthalen-2-ylmethyl]-piperidine-4-carboxylic acid of chemical formula 1 or a pharmaceutically acceptable salt thereof.

Patent Information

Application #

Filing Date

11 November 2023

Publication Number

38/2024

Publication Type

INA

Invention Field

CHEMICAL

Status

Email

Parent Application

Applicants

LG CHEM, LTD.

128, Yeoui-daero Yeongdeungpo-gu Seoul 07336

Inventors

1. KIM, Ji Yoon

E8 Block LG Science Park, 30, Magokjungang 10-ro Gangseo-gu Seoul 07796

2. CHUN, Seul Ah

E8 Block LG Science Park, 30, Magokjungang 10-ro Gangseo-gu Seoul 07796

3. PARK, Ki Sook

151, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu Cheongju-si Chungcheongbuk-do 28162

4. KIM, Sung Won

E8 Block LG Science Park, 30, Magokjungang 10-ro Gangseo-gu Seoul 07796

Specification

Documents

Application Documents

#	Name	Date
1	202317077140-STATEMENT OF UNDERTAKING (FORM 3) [11-11-2023(online)].pdf	2023-11-11
2	202317077140-REQUEST FOR EXAMINATION (FORM-18) [11-11-2023(online)].pdf	2023-11-11
3	202317077140-PRIORITY DOCUMENTS [11-11-2023(online)].pdf	2023-11-11
4	202317077140-POWER OF AUTHORITY [11-11-2023(online)].pdf	2023-11-11
5	202317077140-FORM 18 [11-11-2023(online)].pdf	2023-11-11
6	202317077140-FORM 1 [11-11-2023(online)].pdf	2023-11-11
7	202317077140-DRAWINGS [11-11-2023(online)].pdf	2023-11-11
8	202317077140-DECLARATION OF INVENTORSHIP (FORM 5) [11-11-2023(online)].pdf	2023-11-11
9	202317077140-COMPLETE SPECIFICATION [11-11-2023(online)].pdf	2023-11-11
10	202317077140-Proof of Right [07-05-2024(online)].pdf	2024-05-07
11	202317077140-FORM 3 [07-05-2024(online)].pdf	2024-05-07